Detalhe da pesquisa
1.
Classification and regression tree for estimating predictive markers to detect T790M mutations after acquired resistance to first line EGFR-TKI: HOPE-002.
Invest New Drugs
; 40(2): 361-369, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35088212
2.
Efficacy of anti-PD-1/PD-L1 antibodies after discontinuation due to adverse events in non-small cell lung cancer patients (HANSHIN 0316).
BMC Cancer
; 18(1): 946, 2018 Oct 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30285770
3.
[Safe treatment of lung squamous cell carcinoma with nanoparticle albumin-bound Paclitaxel in a patient with a previous hypersensitivity reaction after docetaxel administration].
Gan To Kagaku Ryoho
; 42(3): 375-7, 2015 Mar.
Artigo
em Japonês
| MEDLINE | ID: mdl-25812512
4.
Pulmonary disease caused by rapidly growing mycobacteria: a retrospective study of 44 cases in Japan.
Respiration
; 85(4): 305-11, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-22890130
5.
Tumor-derived semaphorin 4A improves PD-1-blocking antibody efficacy by enhancing CD8+ T cell cytotoxicity and proliferation.
Sci Adv
; 9(20): eade0718, 2023 05 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-37205755
6.
Peripheral T cell cytotoxicity predicts the efficacy of anti-PD-1 therapy for advanced non-small cell lung cancer patients.
Sci Rep
; 12(1): 17461, 2022 10 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-36261600
7.
A case of acute and severe thrombocytopenia due to readministration of rifampicin.
J Infect Chemother
; 17(2): 288-90, 2011 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-20827562
8.
[A case of sarcomatoid carcinoma of the lung successfully treated with carboplatin, paclitaxel and bevacizumab].
Nihon Kokyuki Gakkai Zasshi
; 49(4): 304-8, 2011 Apr.
Artigo
em Japonês
| MEDLINE | ID: mdl-21591461
9.
Bronchial ethanol injection therapy for airway obstruction in lung cancer patients.
Respirol Case Rep
; 9(9): e0816, 2021 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-34354837
10.
Expectoration of tonsillar metastasis of pulmonary pleomorphic carcinoma after pseudoprogression: A case report.
Thorac Cancer
; 12(12): 1935-1939, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33973724
11.
EGFR-mutant lung adenocarcinoma associated with antisynthetase syndrome successfully treated with osimertinib.
Thorac Cancer
; 12(9): 1441-1444, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33682361
12.
Osimertinib as first-line treatment for advanced epidermal growth factor receptor mutation-positive non-small-cell lung cancer in a real-world setting (OSI-FACT).
Eur J Cancer
; 159: 144-153, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34749119
13.
Real-world survey of pneumonitis and its impact on durvalumab consolidation therapy in patients with non-small cell lung cancer who received chemoradiotherapy after durvalumab approval (HOPE-005/CRIMSON).
Lung Cancer
; 161: 86-93, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34543942
14.
Safety and effectiveness of pirfenidone combined with carboplatin-based chemotherapy in patients with idiopathic pulmonary fibrosis and non-small cell lung cancer: A retrospective cohort study.
Thorac Cancer
; 11(11): 3317-3325, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32986306
15.
Continued administration of pembrolizumab for adenocarcinoma of the lung after the onset of fulminant type 1 diabetes mellitus as an immune-related adverse effect: A case report.
Thorac Cancer
; 10(5): 1276-1279, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30964601
16.
Monitoring antibody binding to T cells in a pembrolizumab-treated patient with lung adenocarcinoma on hemodialysis.
Thorac Cancer
; 10(11): 2183-2187, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31520515
17.
Febrile neutropenia with bacterial paronychia.
Clin Case Rep
; 6(3): 543-544, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29531738
18.
Post-progression survival after cessation of treatment with nivolumab for advanced non-small cell lung cancer: A retrospective study.
PLoS One
; 13(8): e0203070, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30153300
19.
Hyperprogressive disease in patients with non-small cell lung cancer treated with nivolumab: A case series.
Thorac Cancer
; 9(12): 1782-1787, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30328672
20.
Two cases of response to pembrolizumab in epidermal growth factor receptor mutated lung adenocarcinoma patients with programmed death-ligand 1 overexpression.
Ann Transl Med
; 6(22): 444, 2018 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-30596074